Home >> Life Sciences >> Pharmaceuticals

Kuhnil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2015

Published: Jul-2015 | Format: PDF | Global Markets Direct | Number of pages: 38 | Code: MRS - 31494

Kuhnil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Kuhnil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2015’, provides an overview of the Kuhnil Pharmaceutical Co., Ltd.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Kuhnil Pharmaceutical Co., Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Kuhnil Pharmaceutical Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Kuhnil Pharmaceutical Co., Ltd.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Kuhnil Pharmaceutical Co., Ltd.’s pipeline products

Reasons to buy

- Evaluate Kuhnil Pharmaceutical Co., Ltd.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Kuhnil Pharmaceutical Co., Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Kuhnil Pharmaceutical Co., Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Kuhnil Pharmaceutical Co., Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Kuhnil Pharmaceutical Co., Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Kuhnil Pharmaceutical Co., Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Kuhnil Pharmaceutical Co., Ltd. Snapshot 5
Kuhnil Pharmaceutical Co., Ltd. Overview 5
Key Information 5
Key Facts 5
Kuhnil Pharmaceutical Co., Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
Kuhnil Pharmaceutical Co., Ltd. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Kuhnil Pharmaceutical Co., Ltd. - Pipeline Products Glance 12
Kuhnil Pharmaceutical Co., Ltd. - Late Stage Pipeline Products 12
Phase III Products/Combination Treatment Modalities 12
Kuhnil Pharmaceutical Co., Ltd. - Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
Kuhnil Pharmaceutical Co., Ltd. - Early Stage Pipeline Products 15
Preclinical Products/Combination Treatment Modalities 15
Discovery Products/Combination Treatment Modalities 16
Kuhnil Pharmaceutical Co., Ltd. - Drug Profiles 17
KI-0501 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
nimotuzumab 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
KI-0503 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
KI-1102 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
KI-1104 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
KI-0801 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
KI-1002 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
KI-1003 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
KI-1007 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
KI-1101 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
KI-1103 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
KI-1105 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Kuhnil Pharmaceutical Co., Ltd. - Pipeline Analysis 31
Kuhnil Pharmaceutical Co., Ltd. - Pipeline Products by Target 31
Kuhnil Pharmaceutical Co., Ltd. - Pipeline Products by Route of Administration 32
Kuhnil Pharmaceutical Co., Ltd. - Pipeline Products by Molecule Type 33
Kuhnil Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action 34
Kuhnil Pharmaceutical Co., Ltd. - Recent Pipeline Updates 35
Kuhnil Pharmaceutical Co., Ltd. - Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Appendix 37
Methodology 37
Coverage 37
Secondary Research 37
Primary Research 37
Expert Panel Validation 37
Contact Us 37
Disclaimer 38

List of Tables
Kuhnil Pharmaceutical Co., Ltd., Key Information 5
Kuhnil Pharmaceutical Co., Ltd., Key Facts 5
Kuhnil Pharmaceutical Co., Ltd. - Pipeline by Indication, 2015 7
Kuhnil Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2015 8
Kuhnil Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2015 9
Kuhnil Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2015 10
Kuhnil Pharmaceutical Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2015 11
Kuhnil Pharmaceutical Co., Ltd. - Phase III, 2015 12
Kuhnil Pharmaceutical Co., Ltd. - Phase II, 2015 13
Kuhnil Pharmaceutical Co., Ltd. - Phase I, 2015 14
Kuhnil Pharmaceutical Co., Ltd. - Preclinical, 2015 15
Kuhnil Pharmaceutical Co., Ltd. - Discovery, 2015 16
Kuhnil Pharmaceutical Co., Ltd. - Pipeline by Target, 2015 31
Kuhnil Pharmaceutical Co., Ltd. - Pipeline by Route of Administration, 2015 32
Kuhnil Pharmaceutical Co., Ltd. - Pipeline by Molecule Type, 2015 33
Kuhnil Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action, 2015 34
Kuhnil Pharmaceutical Co., Ltd. - Recent Pipeline Updates, 2015 35
Kuhnil Pharmaceutical Co., Ltd., Other Locations 36

List of Figures
Kuhnil Pharmaceutical Co., Ltd. - Pipeline by Top 10 Indication, 2015 7
Kuhnil Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2015 8
Kuhnil Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2015 9
Kuhnil Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2015 10
Kuhnil Pharmaceutical Co., Ltd. - Pipeline by Top 10 Molecule Type, 2015 33

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields


Related Reports

China Fibrinogen Concentrate Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022

Nov-2017 | Global Info Research | Pages : 118 | Code : MRS-182756 | 4480

Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Also known as “fibrin glue” or “fibrin sealant”, the majority of available formulations contain a mixture of pooled plasma-derived fibrinogen and the enzyme thrombin. Scope of the Report: This report focuses on the Fibrinogen Concentr Read more

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Guaifenesin (API) Market 2017 Forecast to 2022

Nov-2017 | Global Info Research | Pages : 120 | Code : MRS-182353 | 4880

Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways. Scope of the Report: This report focuses on the Guaifenesin (API) in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Read more

Global Soy and Milk Protein Ingredients Industry Market Research 2017

Nov-2017 | HJResearch | Pages : 146 | Code : MRS-182254 | 2600

In this report, we analyze the Soy and Milk Protein Ingredients industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2 Read more

Global Medical Oxygen Gas Cylinder Industry Market Research 2017

Nov-2017 | HJResearch | Pages : 164 | Code : MRS-182247 | 2600

In this report, we analyze the Medical Oxygen Gas Cylinder industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. Read more

Global Medical X-Ray Film Processor Industry Market Research 2017

Nov-2017 | HJResearch | Pages : 147 | Code : MRS-182246 | 2600

In this report, we analyze the Medical X-Ray Film Processor industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. Read more

Global Medical Fiberscope Industry Market Research 2017

Nov-2017 | HJResearch | Pages : 157 | Code : MRS-182241 | 2600

In this report, we analyze the Medical Fiberscope industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. We also m Read more

Global Intraocular Lenses Industry Market Research 2017

Nov-2017 | HJResearch | Pages : 161 | Code : MRS-182234 | 2600

In this report, we analyze the Intraocular Lenses industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. We also m Read more

Global Electrophysiology Devices Industry Market Research 2017

Nov-2017 | HJResearch | Pages : 162 | Code : MRS-182224 | 2600

In this report, we analyze the Electrophysiology Devices industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. We Read more

Global Maca Extract Industry Market Research 2017

Oct-2017 | HJResearch | Pages : 146 | Code : MRS-182199 | 2600

In this report, we analyze the Maca Extract industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. We also make a Read more

Global Human Endostatin Industry Market Research 2017

Oct-2017 | HJResearch | Pages : 153 | Code : MRS-182179 | 2600

In this report, we analyze the Human Endostatin industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. We also mak Read more

Single User | $(USD)1500 View Pricing